Coronavirus

                                 Coronavirus

 China Country Office was informed of cases of pneumonia

unknown detected in Wuhan City, Hubei Province of China. From 

31 December 2019 through 3 January 2020, a total of 44 case-patients with pneumonia of 

unknown etiology were reported to WHO by the national authorities in China. During this 

reported period, the causal agent was not identified.

Laterally it was identified as Corona virus.

Symptoms

• runny nose
• headache
• cough
• sore throat
• fever
• a general feeling of being unwell
• Human coronaviruses can sometimes cause lower-respiratory tract illnesses, such as pneumonia or bronchitis. This is more common in people with cardiopulmonary disease, people with weakened immune systems, infants, and older adults.

Diagnosis

Your healthcare provider may order laboratory tests on respiratory specimens and serum (part of your blood) to detect human coronaviruses. Laboratory testing is more likely to be used if you have severe disease or are suspected of having MERS.If you are experiencing symptoms, you should tell your healthcare provider about any recent travel or contact with animals. Most MERS-CoV infections have been reported from countries in the Arabian Peninsula. Therefore reporting a travel history or contact with camels or camel products is very important when trying to diagnose MERS.

PRECAUTIONS

• WHO has been in regular and direct contact with Chinese as well as Japanese, Korean and

Thai authorities since the reporting of these cases. The three countries have shared

information with WHO under the International Health Regulations. WHO is also informing 

other countries about the situation and providing support as requested;

• On 2 January, the incident management system was activated across the three levels of 

WHO (country office, regional office and headquarters);

• Developed the surveillance case definitions for human infection with 2019-nCoV and is 

updating it as per the new information becomes available;

• Developed interim guidance for laboratory diagnosis, clinical management, infection 

prevention and control in health care settings, home care for mild patients, risk 

communication and community engagement;

• Prepared disease commodity package for supplies necessary in identification and 

management of confirmed patients;

• Provided recommendations to reduce risk of transmission from animals to humans;

• Updated the travel advice for international travel in health in relation to the outbreak of 

pneumonia caused by a new coronavirus in China;

• Utilizing global expert networks and partnerships for laboratory, infection prevention and 

control, clinical management and mathematical modelling;

• Activation of R&D blueprint to accelerate diagnostics, vaccines, and therapeutics;

• WHO is working with our networks of researchers and other experts to coordinate global 

work on surveillance, epidemiology, modelling, diagnostics, clinical care and treatment, and 

other ways to identify, manage the disease and limit onward transmission. WHO has issued 

interim guidance for countries, updated to take into account the current situation.